# A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

> **NCT04230252** · PHASE1 · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Acetaminophen

## Key facts

- **NCT ID:** NCT04230252
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-07
- **Primary completion:** 2020-02-10
- **Final completion:** 2020-03-23
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04230252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04230252, "A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04230252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*